Distant metastasis is frequently observed in patients with breast cancer and is a major cause of cancer-related deaths in these patients. Currently, very little is known about the mechanisms that underlie the development of the metastatic phenotype in breast cancer cells. We previously found that metastatic breast cancer cells express high levels of tissue transglutaminase (TG2), but established no direct link between TG2 and metastasis. In this study, we hypothesized that TG2 plays a role in conferring the metastatic phenotype to breast cancer cells. The results obtained suggested that increased expression of TG2 in breast cancer cells contributes to their increased survival, invasion and motility. We further found that TG2 protein in a metastatic breast cancer MDA-MB231 cells was present on the cell surface in close association with integrins b1, b4 and b5. Downregulation of endogenous TG2 by small interfering RNA inhibited fibronectin (Fn)-mediated cell attachment, survival and invasion. Conversely, ectopic expression of TG2 augmented invasion of breast cancer cells and attachment to Fn-coated surfaces. We conclude that TG2 expression in breast cancer cells plays an important role in the development of the metastatic phenotype.
Introduction
Distant metastases rather than primary tumor are the main cause of death in patients with breast cancer. Important steps in the metastatic process include invasion of tumor cells into surrounding host tissues, entry into the blood stream, cell arrest in capillary beds of distant organs, invasion of other host tissues and proliferation (Parker and Sukumar, 2003) . So far, there is no clear understanding of the molecular alterations that govern these steps during the progression of primary tumor cells to metastases. Therefore, the elucidation of novel proteins and pathways that contribute to the transformation of primary tumor cells into metastasis may reveal promising molecular targets for treatment and better clinical management of the disease.
Metastasis is a competitive process that selectively favors the survival and outgrowth of a metastatic subpopulation that pre-exists within the heterogeneous primary tumor. Metastatic tumor cells acquire the ability to disseminate from the primary tumor, whereas others lack this invasive potential (Yoneda, 2000) . Therefore, it should be possible to isolate sub-populations of cancer cells from the parental cell lines that have different invasive and metastatic potential. These subpopulations of cancer cells thus can serve as useful tool for elucidating the molecular mechanisms that contribute in the development of metastatic phenotype. In line with this initiative, we recently showed that sublines isolated from the same parental breast cancer cell line, either in vitro by the limited dilution cloning technique or in vivo by tumorigenicity and metastasis expressed variable levels of the multifunctional protein, tissue transglutaminase (TG2; EC 2.3.2.13) . Similarly, metastatic lymph node tumors from patients with breast cancer consistently showed higher levels of TG2 compared with primary tumors from the same patients.
TG2 is a unique and the most diverse member of the TG2 family of enzymes (Mehta, 2005) . In addition to catalysing the calcium-dependent post-translation modification of proteins, TG2 can also catalyse calciumindependent hydrolysis of guanosine triphosphate (GTP) and adenosine triphosphate, the protein disulfide isomerase reaction (Chandrashekar et al., 1998) and serine/threonine kinase activity (Chen and Mehta, 1999; Fesus and Piacentini, 2002; Lorand and Graham, 2003; Mishra and Murphy, 2004) . The ability of TG2 to hydrolyse GTP enables it to serve as a signaling molecule in transmitting outside signal from a 1b adrenergic receptors to a downstream cytoplasmic target, phospholipase C (Baek et al., 2001) . Although, predominantly a cytosolic protein, TG2 can also be secreted outside the cell where it regulates cell-matrix interactions (Aeschlimann and Thomazy, 2000) ; can translocate to the nucleus where it associates with pRb, p53 and histones to regulate certain cellular functions (Milakovic et al., 2004; ; and can be expressed on the cell membrane in association with b-integrins where it serves as a coreceptor for integrin-mediated binding to fibronectin (Fn) (Akimov and Belkin, 2001) . Cell surface TG2 can affect important cell functions such as attachment, spreading, motility and survival (Balklava et al., 2002; Zemskov et al., 2006) .
In view of these observations and our previous findings that drug-resistant and metastatic breast cancer cells express high levels of TG2, we hypothesized that increased expression of TG2 contributes in the development of metastatic phenotype in breast cancer cells. We found that TG2 is closely associated with integrins b1, b4 and b5 on the surface of metastatic MDA-MB231 breast cancer cells and that this association strongly promotes cell attachment, motility, invasion and resistance to apoptosis. Notably, the inhibition of TG2 by small interfering RNA (siRNA) significantly compromised the ability of MDA-MB231 cells to invade through the Matrigel-transwell membranes, survive in serum-free conditions or adhere to Fn-coated surfaces, suggesting that TG2 expression plays an important role in conferring the metastatic phenotype to breast cancer cells.
Results
To test the hypothesis that TG2 expression plays a role in conferring metastatic phenotype to breast cancer cells, we used two MDA-MB231-derived sublines (MDA231/cl.9 and MDA231/cl.16) that were established on the basis of their differential expression of constitutive TG2 . The MDA231/ cl.9 cells contained low TG2 levels, whereas MDA231/ cl.16 cells showed high constitutive expression of TG2 as determined by analysis of the enzymatic activity, by Western blotting and by immunofluorescent staining (Figure 1 ).
Because increased cell motility is an important feature of metastatic breast cancer cells, we first compared MDA231/cl.16 and MDA231/cl.9 cells for their ability to migrate on Fn-coated surfaces. As shown in Figure 2a and b, TG2-expressing wild-type (WT) MDA-MB231 and MDA231/cl.16 cells migrated far more in number and distance on Fn-coated plates than did the TG2-deficient MDA231/cl.9 cells. On bovine serum albumin (BSA)-coated plates, however, none of the three cell types showed any significant migration (data not shown). Similarly, in an in vitro invasion assay, WT MDA-MB231 and MDA231/cl.16 cells expressing high levels of TG2 showed prominent invasion through the Matrigel-transwell-coated membranes compared with the low TG2-expressing MDA231/cl.9 cells (Figure 2c and d). These results suggest that TG2 expression plays a role in regulating cell migration and invasion functions.
Results of a reverse transcriptase-polymerase chain reaction (RT-PCR) assay to determine if TG2 expression is associated with upregulation of other known metastatic marker genes showed that despite TG2 expression, only the matrix metalloproteinase-1 (MMP-1) transcript was upregulated in invasive MDA231/cl.16 and MDA-MB231 cells (Figure 2e ). Other known markers, such as osteopontin, CXCR4, interleukin-11 and connective tissue growth factor, showed no alteration in their transcript levels in the three MDA-MB231 cell lines. Moreover, RT-PCR analysis of the parental MDA-MB231 (WT) and its two sublines (cl.9 and cl.16) for the expression of other members of the TG family of enzymes (TG1, TG4, TG5, TG7) revealed no detectable expression for any of the known TGs (data not shown).
Because TG2 expression has been shown to promote cell adhesion (Verderio et al., 1998) and to serve as a coreceptor for integrin-mediated binding of cells to Fn , we tested whether TG2 expression in breast cancer cells can promote both the adhesion of cells to Fn and cell survival signaling. Indeed, TG2-expressing MDA231/cl.16 cells showed strong attachment and spreading when cultured on Fncoated surfaces; low TG2 expressing MDA231/cl.9 cells under similar conditions were less adherent (Figure 3a) . On BSA-coated surfaces, however, both cell types were far less adherent and showed a rounded morphology.
We next determined whether TG2-mediated attachment of cells to Fn could confer protection from 
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LS Mangala et al drug-induced cytotoxic effects. We found that TG2-rich MDA231/cl.16 cells cultured on Fn-coated surfaces were more resistant to paclitaxel-induced cell death than were cells cultured on BSA-coated surfaces and that these cells were also more resistant than were MDA231/cl.9 cells with low TG2 expression when cultured on Fn-coated surfaces (Figure 3b ). These results suggest that TG2 expression in cancer cells promotes cell surface interaction with Fn and protects cells from apoptosis. Indeed, it has been well documented that the interaction of cancer cells with Fn can induce cell survival signaling pathways and confer chemoresistance (Zhang et al., 1995; Damiano et al., 1999; Cordes et al., 2003) . Because cell surface TG2 is responsible for mediating the interaction of integrins with Fn by acting as a coreceptor for the extracellular matrix (ECM) ligand, we next determined the levels of cell surface TG2 and integrins in the parental and MDA-MB231 sublines. As shown in Figure 4 , cell surface expression of TG2 in MDA231/cl.16 cells was three-to fivefold higher than in MDA231/cl.9 cells and approximately twofold higher than in the parental MDA-MB231 cells. A comparison of the expression profiles of integrins in the three MDA-MB231 cell lines did not show appreciable differences in b1, b5 and a5 expression. However, the expression of integrins b4, a6 and av was appreciably higher in TG2-rich (WT MDA-MB231 and MDA231/cl.16 cells) than in TG2-low (MDA-MB231/l.9) cells (Figure 4) .
Results of a co-immunoprecipitation assay conducted to further delineate the link between TG2 and integrins clearly established an association between TG2 and integrins b1 (Figure 5a ) and b5 (Figure 5b ). Immunoprecipitation with either of the two b-integrin-specific Figure 2 TG2 expression is associated with increased migration and invasion. (a) A small droplet of agarose containing 10 3 WT, cl.9 or cl.16 MDA-MB231 cells was seeded onto the fibronectin-coated Petri dish, after which cells were allowed to migrate out from the droplet for 48 h at 371C. Migrated cells were fixed, stained and photographed under the phase-contrast microscope (a) or were plotted as ratios between total number of cells versus total distance migrated (b). The Parental (WT) and two subclones (cl.9 and cl.16) of MDA-MB231 cells were compared for their invasive functions in a Matrigel-transwell assay system. Representative fields of cells that migrated under the membrane through the Matrigel were either photographed (c) or 10 fields were counted randomly and average numbers of cells (7s.d.) that migrated were plotted (d). Expression of TG2 and various metastasis-related gene transcripts was studied by RT-PCR in parental (WT) and two subclones (cl.9 and cl.16) of MDA-MB231 cells (e). An amplification product of the glyceraldehydes-3-phosphate dehydrogenase housekeeping gene was used as a loading control. M, molecular weight markers.
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antibodies pulled down TG2 protein and the respective integrin protein, as revealed by immunoblotting. A similar association of TG2 with integrin b4 was observed in MDA231/cl.16 cells (data not shown). However, irrelevant antibodies, such as those directed against the epidermal growth factor receptor, failed to pull down TG2 (data not shown), suggesting a selective interaction between the integrins and TG2. The association between TG2 and integrins was further supported by confocal microscopy data. TG2 colocalized with integrin b1 (Figure 5c ) and integrin b5 (Figure 5d ) in WT MDA-MB231 and MDA231/cl.16 cells, as suggested by the yellow fluorescence in the merged images.
We next determined the involvement of TG2 in Fnmediated cell attachment, survival and invasion by using an siRNA approach (Herman et al., 2006) . Transfection of MDA231/cl.16 cells with control siRNA (scrambled) had no appreciable effect on the TG2 levels. However, the two TG2-specific siRNAs (siRNA1 and siRNA2) blocked TG2 expression by 70-80%, as revealed by Western blotting (Figure 6a ), and enzymatic activity assay (data not shown). We next analysed the effect of transient knockdown of TG2 on Fn-mediated cell attachment. We found that inhibition of TG2 could effectively block the attachment of MDA231/cl.16 cells to Fn-coated surfaces (Figure 6b and c). However, nonFn-mediated adherence (e.g., to polylysine-coated surfaces) was not affected by the lack of TG2 expression. BSA-coated surfaces, on the other hand, failed to promote the attachment of either TG2-expressing or TG2-knockdown MDA231/cl.16 cells (data not shown). These results further suggest that TG2 expression selectively promotes the Fn-mediated attachment of cells.
After a 48-h incubation of untreated and siRNAtransfected cells in serum-free medium in Fn-coated plates, the ability of TG2 and Fn to support cell growth and cell survival functions was determined under serumfree culture conditions by the crystal violet-staining assay. TG2-rich MDA231/cl.16 cells cultured on Fncoated surfaces survived and grew well under serum-free conditions (Figure 7a and b). However, these cells did not survive on BSA-coated surfaces ( Figure 7b ). Importantly, knockdown of TG2 with siRNA markedly reduced the survival and growth of these cells, even when they were cultured on Fn-coated surfaces ( Figure 7a ). These results suggest that the TG2-dependent interaction between breast cancer cells and Fn is critical for inducing cell growth and cell survival signaling.
In a parallel experiment, we also determined the effect of TG2 inhibition on the invasive functions of MDA231/cl.16 by using Matrigel-coated transwell inserts. As observed previously (Figure 2c and d), TG2-rich MDA231/cl.16 cells were highly invasive ( Figure 7c ). However, the inhibition of TG2 by siRNA dramatically inhibited the cells' ability to invade through the Matrigel-coated transwell inserts ( Figure  7c and d). Transfection with control siRNA did not alter this ability, suggesting that TG2 expression promotes invasive functions in breast cancer cells.
To further address the role of TG2 in promoting cell attachment and invasive functions, we overexpressed TG2 by infecting MDA231/cl.9 cells with and high TG2-expressing (cl.16) cells were seeded in BSA-or Fn-coated 96-well plates (2 Â 10 4 cells/well/0.2 ml of serum-free medium). After a 1-h incubation, cells were analysed for attachment after washing and staining with crystal violet, as described in Materials and methods. Results shown are from a representative experiment repeated four times with similar results. (b) Low TG2-expressing (cl.9) and high TG2-expressing (cl.16) MDA-MB231 cells were cultured on BSA-or Fn-coated plates in the presence or absence of 50 nM paclitaxel. After a 24-h treatment, cells were harvested and analysed for apoptosis using the ApoAlert Annexin kit, as described in Materials and methods. Results shown are from a representative experiment repeated at least two times with less than 15% s.d.
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LS Mangala et al adenovirus-containing TG2 construct at 25 multiplicity of infection (MOI). As expected, the overall expression of TG2 in infected MDA231/cl.9 cells increased by three-to fourfolds over the basal level as determined by Western blotting (Figure 8a ) and two-to threefold on the cell surface as determined by flow cytometry (Figure 8b ). Interestingly, forced expression of TG2 was associated with a parallel increase in the invasive potential of MDA231/cl.9 cells (Figure 8c and d) and their ability to attach to Fn-and vitronectin-coated surfaces ( Figure 8e ). Infection of cells with adenovirus vector alone had no effect on TG2 expression or cell adhesion and invasion. However, ectopic expression of a mutant TG2 that lacks transamidation activity owing to point mutation in the active site cysteine residue (C277S) resulted in a similar increase in cell attachment and invasion of MDA231/cl.9 cells (data not shown). These results suggested that TG2 expression plays an important role in promoting the invasive phenotype in breast cancer cells and that the crosslinking activity of TG2 is not essential for conferring these functions.
Discussion
On the basis of the results reported here, we propose that TG2 expression in metastatic breast cancer cells can not only confer apoptosis-resistance phenotype by promoting integrin-mediated cell attachment and cell survival signaling pathways but also promote the cell migration and invasion functions. In an independent study, Jiang et al. (2003a, b) observed that TG2 was one of the 11 metastasis-associated proteins that were selectively amplified in metastatic human lung and breast carcinomas, as revealed by proteomic analysis. Furthermore, these authors reported that tumor cells expressed significantly increased levels of transcripts of TG4 and TG7 compared with the normal mammary tissue. Our current study showed no detectable expression of TG1, TG4, TG5 or TG7 transcripts in metastatic or non-metastatic MDA-MB231 cells. However, TG2 expression was selectively elevated in a metastatic MDA-MB231 subline (cl.16). Moreover, TG2 is closely associated with b1-, b4-and b5-integrins in metastatic TG2 expression and metastasis LS Mangala et al MDA231/cl.16 breast cancer cells and promotes their attachment and motility on Fn-coated surfaces. It is possible that this association of TG2 with cell-surface integrins can promote integrin-mediated cell signaling that could affect not only the adhesion, migration and invasive functions of these cells but also their survival and growth. Indeed, the selective knockdown of TG2 protein using siRNA strongly attenuated their adherence, survival and invasion through Matrigel-coated transwell filters (Figures 6 and 7) . The siRNA-induced inhibition of endogenous TG2 did not alter the expression of cell-surface integrins or MMP-1, suggesting that integrins and MMP-1 requires the presence of TG2 to promote the cell attachment and invasive functions in MDA-231/cl.16 cells. Moreover, ectopic expression of TG2 in MDA-231/cl.9 cells rendered these cells invasive and adherent on Fn-coated surfaces (Figure 8 ), thus further supporting a role for TG2 in these functions. We earlier reported a similar increase in TG2 expression in drug-resistant breast cancer cells (Chen et al., 2002 (Chen et al., , 2004 and the association of TG2 with b-integrins in these cells (Herman et al., 2006) . On the basis of these observations and in view of the highbinding affinity of TG2 for Fn (Jeong et al., 1995; Hang et al., 2005) , we anticipated that TG2 expression would promote the stable interaction of integrins with Fn, the major matrix ligand in the ECM. Indeed, the cell surface interaction with Fn mediated by the a5b1-integrin is an important mediator of cell survival signaling (Longtin, 2004) . For example, the culture of a5b1-integrinexpressing cells on Fn is associated with increased expression of the antiapoptotic protein Bcl2 and thus protects these cells from apoptosis (Zhang et al., 1995) . Similarly, several cancer cell lines have been shown to better survive chemotherapy or radiation-induced cell death when cultured on Fn-coated surfaces (Damiano et al., 1999 (Damiano et al., , 2001 Aoudjit and Vuori, 2001; Cordes et al., 2003; Korah et al., 2004) . The crosstalk between the cell surface a5b1-integrin and Fn leads to the activation of signaling pathways that can induce cell growth and contribute to the development of the metastatic phenotype (Parise et al., 2000; Mehlen and Puisieux, 2006) .
It has been shown that the activation of Shc in response to the interaction of a5b1 and Fn modulates the adhesion and motility of breast cancer MCF-7 cells (Mauro et al., 1999) and that this interaction also results in the activation of Cdc42 and Rac-like GTPases known to contribute to the cell attachment, motility and invasion of cancer cells (Price et al., 1998) . A more recent study demonstrated the direct involvement of cell surface TG2 in integrin-mediated signaling to RhoA/ROCK via integrin clustering and downregulation of the src-p190RhoGAP regulatory pathway . These observations may explain the role of cell surface TG2 in promoting cellular adhesion, cytoskeletal organization, migration and matrix assembly. Similarly, the association of TG2 with a b4 partner in metastatic breast cancer cells may activate a6b4-mediated signaling and affect their 
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Integ. β1 TG2 expression and metastasis LS Mangala et al migration, invasion and survival functions (Lipscomb and Mercurio, 2005) . On the other hand, the high expression of TG2 in metastatic breast cancer cells may explain their higher apoptotic threshold, an important characteristic of metastatic cancer cells that enables them to withstand not only the microenvironmental stresses such as hypoxia, nutritional depletion and low pH but also any chemotherapy-induced cytotoxic effects (Mehlen and Puisieux, 2006) . Indeed, the results reported here supported such a contention by demonstrating the increased resistance of TG2-rich MDA231/cl.16 cells to paclitaxel compared with low TG2-expressing MDA231/cl.9 cells (Figure 3b) . A similar resistance to paclitaxel-induced cytotoxicity has been reported by Aoudjit and Vuori (2001) in MDA-MB231 cells cultured on Fn-coated surfaces. Notably, the inhibition of TG2 protein by siRNA rendered the cells sensitive to apoptosis under serum-free conditions (Figure 7b) . Similarly, inhibition of TG2 expression by siRNA or an antisense approach has been shown to reverse the sensitivity of drug-resistant breast cancer MCF-7 (Herman et al., 2006) and of lung cancer PC-14 cells (Han and Park, 1999) to chemotherapeutic drugs. Moreover, the culture of TG2-positive cells on Fn-coated surfaces has been shown to induce strong activation of the focal adhesion kinase Herman et al., 2006) , an upstream event that leads to the activation of various downstream antiapoptotic and cell survival signaling pathways (Sonoda et al., 2000; McLean et al., 2005) .
In addition to their increased resistance to apoptosis, metastatic cells also acquire an increased ability to migrate and invade. This study further revealed that TG2 expression contributed to the increased ability of TG2-rich MDA231/cl.16 cells to migrate and invade through the Matrigel-coated transwells compared with low TG2-expressing MDA-231/cl.9 cells (Figure 2) . Notably, the downregulation of TG2 by siRNA significantly inhibited the ability of MDA-231/cl.16 cells to attach to Fn-coated surfaces (Figure 6b ) and invade through the Matrigel transwells (Figure 7c and d) . A similar role for TG2 in promoting migration in normal cells has been documented by several recent reports. The first suggested that inhibition of TG2 could block the transmigration of T-lymphocytes across interferontreated and tumor necrosis factor-a-treated endothelial cells (Mohan et al., 2003) . In the second study, the authors observed that the transforming growth factor b-induced increase in the cell surface expression of TG2 was responsible for augmenting the attachment and migration of retinal pigment epithelial cells on Fn-coated surfaces (Priglinger et al., 2004) . Moreover, retinoic acid-induced TG2 expression in neuroblastoma SH-SY5 cells strongly augmented their migration and invasion functions (Joshi et al., 2006) . The authors concluded that in addition to TG2 some other factor(s) was needed to promote retinoic acid-induced migration and invasion because inhibition of TG2 by antisense blocked these functions, but overexpression of TG2 in untreated cells failed to induce any change. Furthermore, Hox A7-mediated downregulation of TG2 was 
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recently shown to inhibit the interaction and migration of differentiated HL-60 cells on Fn-coated surfaces (Leroy et al., 2004) . These observations and our current findings clearly suggest that TG2 expression promotes the cell migration and invasion functions in breast cancer cells. It is possible that alterations such as the constitutive activation of small GTPase RhoA caused by the transamidation reaction catalysed by cytoplasmic TG2 (Singh et al., 2001) or the integrin aggregation induced by cell surface TG2 alter cytoskeletal organization and contribute to the increased ability of TG2-expressing metastatic cells to adhere and migrate. A further understanding of TG2-mediated cellular interactions with the ECM and signaling pathways induced in response to such an interaction may offer new targets for intervention and treatment of metastatic cancer.
Materials and methods
Chemicals and reagents
Unless stated otherwise, all chemicals and reagents were of analytic grade and were purchased from Sigma-Aldrich (St Louis, MO, USA). Primary antibodies against TG2 and b-actin were from Neomarkers (Fremont, CA, USA), whereas antibodies against av-integrin (clone 1953Z), a5-integrin (clone 1956Z), a6-integrin (clone 4F10), b1-integrin (clone 1965Z), b3-integrin (clone 1957Z), b4-integrin (clone ASC-3) and b5-integrin (RB1926) were from Chemicon (Temecula, CA, USA). The secondary antibody, horseradish peroxidaseconjugated anti-mouse immunoglobulin G (IgG) was from Amersham-Pharmacia (San Francisco, CA, USA).
Cell culture
The parental human breast cancer cell line, MDA-MB231, was purchased from American Type Culture Collection (Manassas, VA, USA). MDA-MB231 subclones (MDA231cl.9 and MDA231cl.16) were isolated by the limiting dilution technique as described earlier . All cells were maintained in a log phase of cell growth by culturing in Roswell Park Memorial Institute (RPMI)-1640 medium supplemented with heat-inactivated fetal calf serum (10%, v/v), 0.2% Normocin (InvivoGen, San Diego, CA, USA), 20 mM L-glutamine and 25 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (Life Technologies, Rockville, MD, USA) in a humidified incubator at 371C in the presence of 5% CO 2 and 95% air.
Enzyme activity Cells at 80% confluence were washed in phosphate-buffered saline (PBS), lysed and resuspended in lysis buffer (20 mM 
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Tris-HCl, pH 7.4, containing 1 mM ethylenediaminetetraacetic acid (EDTA), 150 mM NaCl, 0.1% 2-mercaptoethanol and 1 mM L-phenylmethylsulfonyl fluoride). Cells were lysed in the same buffer by probe sonication, followed by the determination of protein content by using a protein-dye reagent (Bio-Rad, Hercules, CA, USA). Cell lysates were then assayed for TG2 activity by determining the Ca 2 þ -dependent incorporation of [ 3 H]putrescine (specific activity, 14.3 Ci/mmol; Amersham Pharmacia) into N,N-dimethylcasein as described previously (Chen et al., 2002) .
Western blotting
Thirty micrograms of cell lysate protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 7.5% gel and electrophoretically transferred onto a nitrocellulose membrane. The membrane was probed with an anti-TG2 monoclonal antibody (CUB7401; Neomarkers). The antigen-antibody reaction was detected by using an electrochemiluminescence system. All membranes were stripped and reprobed with an anti-b-actin antibody (Sigma-Aldrich) at a dilution of 1:2000 to ensure even loading of proteins in the different lanes.
Confocal microscopy
Cells (2 Â 10 5 ) were cultured on glass coverslips in six-well plates, rinsed three times with PBS, fixed with 3.7% paraformaldehyde for 15 min and blocked with 5% normal goat serum for 1 h. The cells were immunostained by using primary antibodies specific to integrins and TG2. Either goat anti-mouse IgG Alexa 488 (or 546) or goat anti-rabbit IgG Alexa 488 (or 546) (Molecular Probes, Eugene, OR, USA) was used as the secondary antibody. The stained coverslips were mounted on glass microscope slides in mounting medium (80% glycerol plus 20% PBS). Slides were visualized under a Zeiss laser scanning microscope 510 (Carl Zeiss Microimaging Inc., Thomwood, NY, USA) and images were obtained.
Cell viability, growth and attachment Ninety-six-well plates (Corning/Costar, Rochester, NY, USA) were coated with 20 mg/ml Fn (Sigma-Aldrich) or 0.1% BSA in PBS. The nonspecific binding sites were blocked with 2% BSA. The cells grown in T-75 flasks to 80-90% confluence were isolated by 2 mM EDTA treatment, washed with RPMI medium and resuspended in serum-free medium (5 Â 10 4 cells/ ml). Aliquots (200 ml) of the cell suspension were added to Fnor BSA-coated wells in quadruplicate and incubated at 371C for 48 h. At the end of incubation period, the number of viable cells remaining in the well was determined by measuring their ability to reduce 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2H-tetrazolium (MTS) into soluble formazan.
In some experiments, cells were transfected with TG2-specific (siRNA1 and siRNA2) or control (scrambled) siRNA as described earlier (Herman et al., 2006) . After 48 h of TG2 expression and metastasis LS Mangala et al transfection, cells were harvested with 2 mM EDTA, washed and assayed for TG2 activity and levels or were plated in quadruplicate in each well of 96-well plates that had been precoated with Fn or BSA. After 48 h of incubation, cells were examined under the light microscope and tested for cell viability by using the MTS assay. For the cell attachment assay, the control and siRNAtransfected cells (2 Â 10 4 cells/well/0.2 ml serum-free RPMI medium) were incubated in Fn-or BSA-coated 96-well plates. After a 1-h incubation at 371C, cells were viewed under a microscope for morphologic analysis. Non-adherent cells were removed by washing with PBS, and adherent cells were fixed with 3.7% paraformaldehyde for 1 h, washed twice with PBS and stained with 0.1% crystal violet for 40 min. The stained cells were washed with water and lysed in 0.5% Triton X-100, after which the optical density was read at 540 nm.
TG2wt and TG2m adenovirus generation
Adenovirus containing full-length TG2 (TG2wt) or C277S mutant (TG2m) cDNA constructs was kindly provided by Dr Ugra Singh (The University of Texas, Temple, TX, USA). Briefly, TG2 cDNA cloned in pcDNA3.1 vector was first subcloned in a pshuttle 2 vector and then in BD adenoX adenoviral vector. Human embryonic kidney-293 cells were transfected with recombinant adenoviral plasmid for packaging of adenovirus particles. Adenovirus was purified on CsCl gradient and used at 25 MOI. Cells infected with lacZ adenovirus served as control.
Cell migration and invasion
Relative cell motility on Fn-coated plates was assayed by determining the extent of outward cell migration from an agarose droplet as described earlier (Balklava et al., 2002) . Briefly, cells were harvested, resuspended at a concentration of 1 Â 10 6 /ml in RPMI medium and mixed with low-melting point agarose (0.2% final concentration) maintained at 381C. The cell suspension in the agarose was then seeded into the center of the Fn-coated Petri dishes. The agarose was allowed to set for 7 min at 41C, after which growth medium was added and left for 48 h at 371C. Cells were then fixed with 3% glutaraldehyde for 30 min, stained with crystal violet (0.5% in 70% ethanol) and air-dried. The number of cells migrating out and away from the agarose was determined by taking a picture under the light microscope.
The invasive behavior of cells was determined in vitro by using Matrigel-transwell inserts, as described earlier . Briefly, transwell inserts with a 12-mm pore size were coated with 0.78 mg/ml Matrigel in cold serum-free medium. Cells were then trypsinized and washed with serumfree medium. The cell pellets were subsequently resuspended in serum-free medium, and 0.5 ml of the cell suspension (1 Â 10 6 cells) was added to duplicate wells. After a 48-h of incubation, the cells that passed through the filter on the underside of the membrane were stained and counted under a light microscope. Ten fields of cells were counted for each well, and the mean number of cells per field was calculated. Each experiment was performed in triplicate and repeated at least two times.
RT-PCR
Total RNA was isolated from the parental MDA-MB231 cell line and its two sublines (cl.9 and cl.16) with Trizol reagent (Invitrogen, San Diego, CA, USA). cDNA was synthesized from 5 mg of total RNA by using SuperScript reverse transcriptase (Life Technologies Inc.) as per the manufacturer's instructions. cDNA was subjected to PCR by using gene-specific primers (Table 1) . PCR was performed with 5-25 mg of reverse-transcribed RNA, 1 U of Taq polymerase and 100 ng/ml of sense and antisense primers in a total volume of 50 ml. Each cycle consisted of 30 s of denaturation at 941C at the different annealing and elongation temperatures shown in Table 1 . Amplified PCR products were analysed by electrophoresis on 1% agarose gel and visualized under the ultraviolet light after staining with ethidium bromide. A mock-RT-PCR reaction, in which the RT was omitted, was always run in parallel as a control.
Effect of paclitaxel on apoptosis
The percentage of early and late apoptotic cells was determined by using the ApoAlert Annexin Kit (BD Biosciences, Franklin Lakes, NJ, USA). Briefly, control and paclitaxel-treated cells were trypsinized and washed twice with PBS. Cells (1 Â 10 6 /ml) were then resuspended in binding buffer, and 150 ml of the cell suspension was incubated with 5 ml of annexin cy5 and 10 ml of propidium iodide for 15 min in the dark at room temperature. The mixtures of cell solution were analysed by a flow cytometer (FACScan; BD Biosciences).
Surface expression of integrins and TG2
Viable cells (WT and two subclones) were detached with 2 mM EDTA and resuspended (2 Â 10 5 cells/100 ml) in 1% BSA in PBS, followed by incubation with 1 mg/100 ml of a primary antibody for 30 min on ice. After washing with PBS, cells were incubated with a fluorescein isothiocyanate-conjugated antimouse IgG secondary antibody (0.2 mg/100 ml) and analysed Immunoprecipitation Four hundred micrograms of total cell lysate protein was used for the immunoprecipitation of integrins b1, b4 and b5 as described (Herman et al., 2006) . Briefly, after preclearing and incubation with an appropriate antibody overnight, antigenantibody complexes were removed by incubation with antimouse IgG or anti-rabbit IgG for 1 h at 41C, followed by incubation with a G-protein sepharose beads (1-3 h at 41C).
Beads were washed with the extraction buffer and eluted with a 2 Â sample buffer. Bound proteins were analysed by Western blotting. To detect TG2 in the immunoprecipitates (IPs), we first probed membranes with an anti-TG2 antibody (M-300, Neomarkers) before stripping and reprobing them with antib1-, anti-b4-or anti-b5-integrin antibodies.
